| AUC | 95% CI | Best cut-off (mg/dl) |
---|---|---|---|
MACE | |||
 Whole population | 0.730 | 0.700–0.760 | 5.2 |
 Females | 0.764 |  | 5.2 |
 Males | 0.688 |  | 5.3 |
Coronary events | |||
 Whole population | 0.710 | 0.673–0.748 | 5.2 |
 Females | 0.747 | 0.699–0.79 | 5.2 |
 Males | 0.692 | 0.634–0.749 | 5.3 |
Cerebrovascular events | |||
 Whole population | 0.649 | 0.595–0.703 | 4.9 |
 Females | 0.695 | 0.612–0.730 | 4.8 |
 Males | 0.586 | 0.504–6.34 | 5.6 |
Overall mortality | |||
 Whole population | 0.709 | 0.639–0.780 | 4.9 |
 Females | 0.753 | 0.663–0.844 | 4.9 |
 Males | 0.677 | 0.573–0781 | 5.3 |